Eli Lilly (NYSE: LLY) Stock Price Gains As CVS Health Broadens Weight-Loss Drug Coverage

Eli Lilly (NYSE: LLY) Stock Price Gains As CVS Health Broadens Weight-Loss Drug Coverage

Eli Lilly (NYSE: LLY) shares moved higher after CVS Health announced plans to expand coverage for several of the company’s weight-loss treatments under its standard drug plans. CVS Health plans to add coverage for Lilly’s weight-loss drug Zepbound starting October 1, with coverage for obesity pill Foundayo set to begin June 1. The decision carries significant weight because CVS manages prescription benefits for millions of Americans, giving Lill…